Immunotherapy using PD‑1/PDL-1 inhibitors in triple‑negative breast cancer: a systematic review

Breast cancer is the most commonly diagnosed cancer in women and is one of the leading causes of death from cancer in women worldwide. Despite the significant benefits of using conventional chemotherapy in the treatment of breast cancer, one of its subtypes, the triple negative breast cancer, is sti...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Dione Tavares, Victoria Chaves Ribeiro, Laércio Moreira Cardoso-Júnior, Thiago Rhangel Gomes Teixeira, Gabriela Ramos Varrone, Renata Lopes Britto
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2021-12-01
Cyfres:	Oncology Reviews
Pynciau:	Triple-negative breast cancer Immunotherapy PD-1 PD-L1 Checkpoint inhibitors
Mynediad Ar-lein:	https://www.oncologyreviews.org/site/article/view/497
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!